Charles Bankhead
Low retreatment rates observed for SUI procedures
Three different procedures to treat stress urinary incontinence led to high rates of recurrence-free outcomes at 5 years, and the choice of retreatment of SUI varied according to the initial procedure, long-term follow-up in two randomized trials showed.
Epigenetic profiling helps avoid unneeded repeat prostate biopsy
Epigenetic profiling of prostate biopsies significantly improved the accuracy of predicting cancer in men with negative results, according to a late-breaking abstract presented at the AUA annual meeting in San Diego.
Assay offers precision in assigning prostate cancer risk categories
Combining a prostate cancer gene assay with standard risk-stratification factors substantially increased information to guide decision making about active surveillance, a validation study of the assay showed.
Urethral ‘lift’ offers improvements in LUTS, urinary flow
A minimally invasive implant procedure led to a 50% improvement in lower urinary tract symptoms due to BPH, which was maintained for a year, results of a randomized trial showed.
Mircohematuria a poor predictor of urinary tract cancer
Asymptomatic microhematuria rarely represented a manifestation of urinary tract cancer in a prospective study involving more than 4,000 patients.
IASLC PODCAST: Gary Strauss, M.D.
In this exclusive podcast with Medpage Today, Gary Strauss, M.D., of Tufts University in Boston, discusses the implications of his study on the predominance of adenocarcinoma histology in lung cancer as it pertains to changes in cigarette design, as well as how it pertains to non-smokers, a call to action to the tobacco industry, and other findings of the study with Medpage Today Staff Writer Charles Bankhead.
  • 1
  • 2